Your browser doesn't support javascript.
loading
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet.
Pasca, Matteo; Picchioni, Antonella; Mazzeo, Salvatore; Terenzi, Federica; Prestipino, Elio; Fratangelo, Roberto; Repice, Anna Maria; Carlucci, Giovanna; Massacesi, Luca; Barilaro, Alessandro.
  • Pasca M; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Picchioni A; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Mazzeo S; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Terenzi F; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Prestipino E; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Fratangelo R; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Repice AM; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Carlucci G; Neurological Division II Careggi University Hospital, Florence, Italy.
  • Massacesi L; Department of Neurological and Psychiatric sciences (NEUROFARBA), University of Florence, Florence, Italy.
  • Barilaro A; Neurological Division II Careggi University Hospital, Florence, Italy.
Intractable Rare Dis Res ; 8(4): 275-278, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31890456
ABSTRACT
We reported the case of a John Cunningham virus (JCV) and human herpesvirus 6 (HHV-6) mediated progressive multifocal leukoencephalopathy (PML) after human stem cell transplant, reactivated 6 months later in absence of immunosuppressive therapy, successfully treated with anti-5HT2A receptors agents and antiviral therapy. Few cases of JCV and HHV-6 coinfection associated PML are described in literature and the role of HHV-6 in the pathogenesis and prognosis of PML is not completely clear. Our case suggests that, in a possible PML, the research of HHV-6 and JCV should be always performed on cerebrospinal fluid (CSF) and on blood samples and in case of detection of HHV-6 DNA a chromosomally integrated human herpesvirus 6(ciHHV-6) should be excluded. Furthermore we recommend to start an appropriate therapy with antiviral and anti-5HT2A receptors agents in case of possible PML due to JCV and HHV-6 coinfection.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Año: 2019 Tipo del documento: Article